Barth syndrome and the search for therapeutic approaches
Les maladies mitochondriales sont diverses, pléiotropes, graves et en grande partie sans traitement. Parmi elles, le syndrome de Barth (BTHS - Barth Syndrome) qui est une cardiomyopathie rare liée à l’X, est causée par des mutations dans le gène ...
Almyre, Claire
core
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathy. [PDF]
Oyarbide U +10 more
europepmc +1 more source
Emerging roles of pyruvate dehydrogenase phosphatase 1: a key player in metabolic health. [PDF]
Kumar V, Greenberg ML.
europepmc +1 more source
Cranial, Renal, and Skeletal Anomalies in a Fetus With a Pathogenic Variant in the TAFAZZIN Gene. [PDF]
Muir CR, Gilmore KL, Singh S, Vora NL.
europepmc +1 more source
Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. [PDF]
Sabbah HN +8 more
europepmc +1 more source
Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts. [PDF]
Piñeiro-Llanes J +8 more
europepmc +1 more source
ECG Findings Are Poor Predictors for Adverse Events and Cardiac Death in Barth Syndrome. [PDF]
Hutchinson A +3 more
europepmc +1 more source
Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. [PDF]
Yu J +7 more
europepmc +1 more source
Sensor-based digital health technologies to capture endpoints in recent clinical trials: a scoping review. [PDF]
Garcia J +7 more
europepmc +1 more source
Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts. [PDF]
Mejia EM +3 more
europepmc +1 more source

